Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Colombo C; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy., Minna E; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargiuli C; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muzza M; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Dugo M; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pogliaghi G; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Tosi D; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Bulfamante G; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Greco A; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fugazzola L; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. laura.fugazzola@unimi.it.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy. laura.fugazzola@unimi.it., Borrello MG; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. MariaGrazia.Borrello@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Nov 16; Vol. 39 (1), pp. 245. Date of Electronic Publication: 2020 Nov 16.
Autor:
Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Renzi TA; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perrone M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tomirotti AM; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology - Bioinformatics, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bongiovanni L; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Marrale M; Department of Physics and Chemistry, University of Palermo, Palermo, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Cancer research [Cancer Res] 2020 Feb 01; Vol. 80 (3), pp. 484-498. Date of Electronic Publication: 2019 Nov 27.
Autor:
Pintarelli G; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Noci S; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Maspero D; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pettinicchio A; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Incarbone M; Department of Surgery, IRCCS MultiMedica, Sesto S.G., Italy., Tosi D; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Santambrogio L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Dragani TA; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. tommaso.dragani@istitutotumori.mi.it., Colombo F; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Scientific reports [Sci Rep] 2019 Sep 10; Vol. 9 (1), pp. 13039. Date of Electronic Publication: 2019 Sep 10.
Autor:
Callari M; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. Maurizio.Callari@cruk.cam.ac.uk.; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Maurizio.Callari@cruk.cam.ac.uk., Dugo M; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. matteo.dugo@istitutotumori.mi.it., Miodini P; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. patrizia.miodini@istitutotumori.mi.it., Veneroni S; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. silvia.veneroni@istitutotumori.mi.it., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, 20132 Milano, Italy. bianchini.giampaolo@hsr.it., Daidone MG; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. mariagrazia.daidone@istitutotumori.mi.it., Cappelletti V; Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy. vera.cappelletti@istitutotumori.mi.it.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2018 Jan 09; Vol. 19 (1). Date of Electronic Publication: 2018 Jan 09.
Autor:
Dugo M; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cotroneo CE; Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lavoie-Charland E; Institut Universitaire de cardiologie et de pneumologie de Québec, Québec, Canada., Incarbone M; Department of Surgery, San Giuseppe Hospital-MultiMedica, Milan, Italy., Santambrogio L; Fondazione IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Rosso L; Fondazione IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., van den Berge M; University of Groningen, University Medical Center Groningen, Department of Pulmonology, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Nickle D; Merck & Co. Inc., Rahway, NJ, United States of America., Paré PD; University of British Columbia Center for Heart Lung Innovation and Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, BC, Canada.; Respiratory Division, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Bossé Y; Institut Universitaire de cardiologie et de pneumologie de Québec, Québec, Canada.; Department of Molecular Medicine, Laval University, Québec, Canada., Dragani TA; Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Colombo F; Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
PloS one [PLoS One] 2016 Nov 30; Vol. 11 (11), pp. e0167460. Date of Electronic Publication: 2016 Nov 30 (Print Publication: 2016).
Autor:
Huang X; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Dugo M; Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Callari M; Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sandri M; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Valeri B; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Carcangiu ML; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Xue J; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Bi R; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Veneroni S; Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Daidone MG; Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ménard S; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Shao Z; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Orlandi R; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Cancer medicine [Cancer Med] 2015 Jul; Vol. 4 (7), pp. 1016-30. Date of Electronic Publication: 2015 Mar 18.
Autor:
Galvan A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Frullanti E, Anderlini M, Manenti G, Noci S, Dugo M, Ambrogi F, De Cecco L, Spinelli R, Piazza R, Pirola A, Gambacorti-Passerini C, Incarbone M, Alloisio M, Tosi D, Nosotti M, Santambrogio L, Pastorino U, Dragani TA
Publikováno v:
Carcinogenesis [Carcinogenesis] 2013 Dec; Vol. 34 (12), pp. 2767-73. Date of Electronic Publication: 2013 Aug 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rinchai, Darawan, Verzoni, Elena, Huber, Veronica, Cova, Agata, Squarcina, Paola, De Cecco, Loris, Braud, Filippo, Ratta, Raffaele, Dugo, Matteo, Lalli, Luca, Vallacchi, Viviana, Rodolfo, Monica, Roelands, Jessica, Castelli, Chiara, Chaussabel, Damien, Procopio, Giuseppe, Bedognetti, Davide, Rivoltini, Licia
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Background The combination of immune checkpoint blockade (ICB) with standard therapies is becoming a common approach for overcoming resistance to cancer immunotherapy in most human malignancies including metastatic renal cell carcinoma (mRCC). In thi
Autor:
Laura Botti, Valeria Cancila, Tiziana Ada Renzi, Mario P. Colombo, Maurizio Marrale, Sabina Sangaletti, Claudio Tripodo, Lucia Bongiovanni, Milena Perrone, Matteo Milani, Andrea Massimiliano Tomirotti, Claudia Chiodoni, Matteo Dugo
Publikováno v:
Cancer research. 80(3)
The presence of a growing tumor establishes a chronic state of inflammation that acts locally and systemically. Bone marrow responds to stress signals by expanding myeloid cells endowed with immunosuppressive functions, further fostering tumor growth